XML 25 R15.htm IDEA: XBRL DOCUMENT
v3.23.1

ACCRUED EXPENSES | 3 Months Ended
--- | ---
Mar. 31, 2023
Payables and Accruals [Abstract] |
ACCRUED EXPENSES | 9. ACCRUED EXPENSES The following table summarizes the Company’s accrued expenses for each of the periods indicated:
|  | As of March 31, 2023 |  |  | As of December 31, 2022 |
|  | (in thousands) |
Accrued contract manufacturing costs |  | $ | 155,609 |  |  | $ | 202,173 |
Product revenue related reserves |  |  | 68,692 |  |  |  | 68,784 |
Accrued clinical and pre-clinical costs |  |  | 35,968 |  |  |  | 28,884 |
Accrued employee compensation costs |  |  | 27,849 |  |  |  | 65,946 |
Accrued professional fees |  |  | 18,972 |  |  |  | 12,061 |
Accrued income taxes |  |  | 16,092 |  |  |  | 12,521 |
Accrued royalties |  |  | 8,383 |  |  |  | 8,636 |
Accrued fixed assets |  |  | 7,451 |  |  |  | 984 |
Accrued research costs |  |  | 2,177 |  |  |  | 1,629 |
Other |  |  | 4,361 |  |  |  | 17,378 |
Total accrued expenses |  | $ | 345,554 |  |  | $ | 418,996 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration